These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Assessment of Mortality-Related Risk Factors and Effective Antimicrobial Regimens for Treatment of Bloodstream Infections Caused by Carbapenem-Resistant Chen L; Han X; Li Y; Li M Antimicrob Agents Chemother; 2021 Aug; 65(9):e0069821. PubMed ID: 34228539 [TBL] [Abstract][Full Text] [Related]
9. Validation of the INCREMENT-SOT-CPE score in a large cohort of liver transplant recipients with carbapenem-resistant Enterobacterales infection. Rinaldi M; Bonazzetti C; Gallo M; Ferraro G; Freire M; Terrabuio DRB; Tandoi F; Romagnoli R; De Rosa FG; Mularoni A; Ferrarese A; Burra P; Halpern M; Balbi E; Simkins J; Abbo L; Morrás I; Cantero M; Alagna L; Bandera A; Clemente WT; Valerio M; Fernández A; Muñoz P; Statlender L; Yahav D; Camargo LFA; Girão ES; Grossi P; Viale P; Curti S; Giannella M; Transpl Infect Dis; 2023 Apr; 25(2):e14036. PubMed ID: 36880576 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae. Pérez-Nadales E; Fernández-Ruiz M; Natera AM; Gutiérrez-Gutiérrez B; Mularoni A; Russelli G; Pierrotti LC; Pinheiro Freire M; Falcone M; Tiseo G; Tumbarello M; Raffaelli F; Abdala E; Bodro M; Gervasi E; Fariñas MC; Seminari EM; Castón JJ; Marín-Sanz JA; Gálvez-Soto V; Rana MM; Loeches B; Martín-Dávila P; Pascual Á; Rodríguez-Baño J; Aguado JM; Martínez-Martínez L; Torre-Cisneros J; Am J Transplant; 2023 Jul; 23(7):1022-1034. PubMed ID: 37028515 [TBL] [Abstract][Full Text] [Related]
11. Herrera S; Morata L; Sempere A; Verdejo M; Del Rio A; Martínez JA; Cuervo G; Hernández-Meneses M; Chumbita M; Pitart C; Puerta P; Monzó P; Lopera C; Aiello F; Mendoza S; Garcia-Vidal C; Soriano A; Bodro M Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830291 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project). Pierrotti LC; Pérez-Nadales E; Fernández-Ruiz M; Gutiérrez-Gutiérrez B; Tan BH; Carratalà J; Oriol I; Paul M; Cohen-Sinai N; López-Medrano F; San-Juan R; Montejo M; Freire MP; Cordero E; David MD; Merino E; Mehta Steinke S; Grossi PA; Cano Á; Seminari EM; Valerio M; Gunseren F; Rana M; Mularoni A; Martín-Dávila P; van Delden C; Hamiyet Demirkaya M; Koçak Tufan Z; Loeches B; Iyer RN; Soldani F; Eriksson BM; Pilmis B; Rizzi M; Coussement J; Clemente WT; Roilides E; Pascual Á; Martínez-Martínez L; Rodríguez-Baño J; Torre-Cisneros J; Aguado JM; Transpl Infect Dis; 2021 Jun; 23(3):e13520. PubMed ID: 33222379 [TBL] [Abstract][Full Text] [Related]
13. Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network). Falcone M; Tiseo G; Carbonara S; Marino A; Di Caprio G; Carretta A; Mularoni A; Mariani MF; Maraolo AE; Scotto R; Dalfino L; Corbo L; Macera M; Medaglia AA; d'Errico ML; Gioè C; Sgroi C; Del Vecchio RF; Ceccarelli G; Albanese A; Buscemi C; Talamanca S; Raponi G; Foti G; De Stefano G; Franco A; Iacobello C; Corrao S; Morana U; Pieralli F; Gentile I; Santantonio T; Cascio A; Coppola N; Cacopardo B; Farcomeni A; Venditti M; Menichetti F; Clin Infect Dis; 2023 Jun; 76(12):2059-2069. PubMed ID: 36801828 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Chen Y; Huang HB; Peng JM; Weng L; Du B Microbiol Spectr; 2022 Apr; 10(2):e0260321. PubMed ID: 35377233 [TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics of carbapenem-resistant Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384 [No Abstract] [Full Text] [Related]
17. Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections Among Solid Organ Transplant Recipients. Hong Nguyen M; Shields RK; Chen L; William Pasculle A; Hao B; Cheng S; Sun J; Kline EG; Kreiswirth BN; Clancy CJ Clin Infect Dis; 2022 Feb; 74(3):395-406. PubMed ID: 33970222 [TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistant organism bloodstream infections in solid organ transplant recipients and impact on mortality: a systematic review. Liu AJ; Dennis ASM; Fariha Z; Pai Mangalore R; Macesic N JAC Antimicrob Resist; 2024 Oct; 6(5):dlae152. PubMed ID: 39386374 [TBL] [Abstract][Full Text] [Related]
19. Bloodstream infections after solid organ transplantation: clinical epidemiology and antimicrobial resistance (2016-21). Adelman MW; Connor AA; Hsu E; Saharia A; Mobley CM; Victor DW; Hobeika MJ; Lin J; Grimes KA; Ramos E; Pedroza C; Brombosz EW; Ghobrial RM; Arias CA JAC Antimicrob Resist; 2024 Feb; 6(1):dlad158. PubMed ID: 38213312 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients. Zhang Y; Guo LY; Song WQ; Wang Y; Dong F; Liu G BMC Infect Dis; 2018 May; 18(1):248. PubMed ID: 29855274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]